Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Serbia May Offer Minority Stake in Drug Maker Galenika to EBRD

Oct. 30 (Bloomberg) -- Serbia, which is restructuring state-owned drugmaker Galenika AD and may offer a stake to the European Bank for Reconstruction and Development.

The Zemun, Serbia-based company, whose 2011 loss widened to 20 million euros ($26 million), may return to profitability this year or next after the “restructuring that is both financial and operational,” and includes efforts to collect 90 million euros owed by drug wholesalers Velefarm AD and BG Farm, General Manager Zivomir Novakovic said in a phone interview today.

A minority stake may be offered to the London-based EBRD or another international financial organization after the overhaul as the government will probably want to keep a controlling stake in the company, Novakovic said.

The government said last week it will no longer back liquidity loans for its unprofitable companies. Earlier this year, Galenika received guarantees to borrow 70 million euros ($91 million) to service debt and pay suppliers.

To contact the reporter on this story: Misha Savic in Belgrade at

To contact the editor responsible for this story: James M. Gomez at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.